The new HCT-CI scores and prediction for NRM and survival the training versus the validation set
. | Training set . | . | . | Validation set . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | . | NRM . | . | . | NRM . | . | ||||
| Score . | Patients, % . | HR*(95% CI) . | 2-year, % . | Patients, % . | HR*(95% CI) . | 2-year, % . | ||||
| 0 | 38 | 1 | 9 | 38 | 1 | 14 | ||||
| 1 | 17 | 1.66 (0.9-3.1) | 14 | 18 | 1.57 (0.7-3.3) | 22 | ||||
| 2 | 17 | 3.48 (2.0-6.0) | 27 | 17 | 1.26 (0.6-2.8) | 19 | ||||
| 3 | 17 | 6.09 (3.7-10.1) | 41 | 15 | 3.95 (2.1-7.5) | 41 | ||||
| 4 or more | 11 | 6.93 (4.0-12.0) | 43 | 13 | 3.05 (1.5-6.2) | 40 | ||||
. | Training set . | . | . | Validation set . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | . | NRM . | . | . | NRM . | . | ||||
| Score . | Patients, % . | HR*(95% CI) . | 2-year, % . | Patients, % . | HR*(95% CI) . | 2-year, % . | ||||
| 0 | 38 | 1 | 9 | 38 | 1 | 14 | ||||
| 1 | 17 | 1.66 (0.9-3.1) | 14 | 18 | 1.57 (0.7-3.3) | 22 | ||||
| 2 | 17 | 3.48 (2.0-6.0) | 27 | 17 | 1.26 (0.6-2.8) | 19 | ||||
| 3 | 17 | 6.09 (3.7-10.1) | 41 | 15 | 3.95 (2.1-7.5) | 41 | ||||
| 4 or more | 11 | 6.93 (4.0-12.0) | 43 | 13 | 3.05 (1.5-6.2) | 40 | ||||
For the training set, n = 708; for the validation set, n = 346.
Adjusted for age, disease risk, and conditioning.